Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions - Top-Institutions - MDSpire

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

  • By

  • Hee Bum Jo

  • Jong Su Kang

  • Sungim Choi

  • Seong Yeon Park

  • May 25, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Medicine – The Johns Hopkins Hospital
    Johns Hopkins Medicine – The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Infectious Disease

  • #2

    Mass General Brigham (Massachusetts General Hospital and Brigham and Women’s Hospital)
    Mass General Brigham (Massachusetts General Hospital and Brigham and Women’s Hospital)

    Boston, Massachusetts

    Key Differentiators

    • Infectious Disease

  • #3

    Centre Hospitalier Universitaire (CHU), Montpellier
    Centre Hospitalier Universitaire (CHU), Montpellier

    Montpellier, France

    Key Differentiators

    • Infectious Disease

Original Source(s)

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

  • by Hee Bum Jo, Jong Su Kang, Sungim Choi, Seong Yeon Park

  • May 25, 2026

Related Content

Human Papillomavirus Vaccine Discourse and Sentiment on Reddit Before and After COVID-19: Mixed Methods Retrospective Cross-Sectional Study

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

“Who’s on Backup?”—Exploring Internal Medicine Residency Backup Coverage Systems: Findings from a National Survey